Skip to main content
Journal cover image

Plasma acylcarnitines are associated with pulmonary hypertension.

Publication ,  Journal Article
Luo, N; Craig, D; Ilkayeva, O; Muehlbauer, M; Kraus, WE; Newgard, CB; Shah, SH; Rajagopal, S
Published in: Pulm Circ
March 2017

Quantifying metabolic derangements in pulmonary hypertension (PH) by plasma metabolomics could identify biomarkers useful for diagnosis and treatment. The objective of this paper is to test the hypotheses that circulating metabolites are differentially expressed in PH patients compared with controls and among different hemodynamic subtypes of PH associated with left heart disease. We studied patients enrolled in the CATHGEN biorepository with PH (right heart catheterization mPAP ≥ 25 mmHg; n = 280). Of these, 133 met criteria for postcapillary PH, 82 for combined precapillary and postcapillary PH (CpcPH), and 65 for precapillary PH. Targeted profiling of 63 metabolites (acylcarnitines, amino acids, and ketones) was performed using tandem flow injection mass spectrometry. Multivariable linear regression was used to determine differences in metabolite factors derived from a principal components analysis between PH cases, PH subtypes, and non-PH controls. In adjusted models, the metabolite factor loaded with long-chain acylcarnitines was higher in all PH cases versus non-PH controls (P = 0.00008), but did not discriminate between CpcPH and postcapillary PH (P = 0.56). In analyses of subtypes, CpcPH patients had lower levels of factors loaded with urea cycle amino acids and short chain acylcarnitines as compared to controls (P = 0.002 and P = 0.01, respectively) and as compared to postcapillary PH (P = 0.04 and P = 0.02, respectively). Compared to controls, PH was strongly associated with greater concentrations of long-chain acylcarnitines. Postcapillary PH and CpcPH were weakly associated with distinct metabolomic profiles. These findings suggest the presence of unique metabolic abnormalities in subtypes of PH and may reflect underlying pathophysiology.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Pulm Circ

DOI

ISSN

2045-8932

Publication Date

March 2017

Volume

7

Issue

1

Start / End Page

211 / 218

Location

United States

Related Subject Headings

  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Luo, N., Craig, D., Ilkayeva, O., Muehlbauer, M., Kraus, W. E., Newgard, C. B., … Rajagopal, S. (2017). Plasma acylcarnitines are associated with pulmonary hypertension. Pulm Circ, 7(1), 211–218. https://doi.org/10.1086/690554
Luo, Nancy, Damian Craig, Olga Ilkayeva, Michael Muehlbauer, William E. Kraus, Christopher B. Newgard, Svati H. Shah, and Sudarshan Rajagopal. “Plasma acylcarnitines are associated with pulmonary hypertension.Pulm Circ 7, no. 1 (March 2017): 211–18. https://doi.org/10.1086/690554.
Luo N, Craig D, Ilkayeva O, Muehlbauer M, Kraus WE, Newgard CB, et al. Plasma acylcarnitines are associated with pulmonary hypertension. Pulm Circ. 2017 Mar;7(1):211–8.
Luo, Nancy, et al. “Plasma acylcarnitines are associated with pulmonary hypertension.Pulm Circ, vol. 7, no. 1, Mar. 2017, pp. 211–18. Pubmed, doi:10.1086/690554.
Luo N, Craig D, Ilkayeva O, Muehlbauer M, Kraus WE, Newgard CB, Shah SH, Rajagopal S. Plasma acylcarnitines are associated with pulmonary hypertension. Pulm Circ. 2017 Mar;7(1):211–218.
Journal cover image

Published In

Pulm Circ

DOI

ISSN

2045-8932

Publication Date

March 2017

Volume

7

Issue

1

Start / End Page

211 / 218

Location

United States

Related Subject Headings

  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology